- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Prioritizing Goals Of Treatment In Patients Diagnosed With Bipolar I Disorder: Results From A US Patient Survey Using Best-Worst Scaling

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Prioritizing Goals Of Treatment In Patients Diagnosed With Bipolar I Disorder: Results From A US Patient Survey Using Best-Worst Scaling
When treating people with bipolar disorder it is important to understand the patient’s perception and prioritization of their goals of treatment. This webinar will discuss how to develop strategies to assess patient preferences regarding new preventative treatments such as mode of administration and dosing regimen, and explore potential differences in goals of treatment and preferences among selected subgroups of patients with BP-I. Together the presenters will review the results of a survey that asks these questions of people diagnosed with bipolar I disorder and discuss not only the results and outcomes but the potential clinical implications.

Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
More

Karimah S. B. Lynum, PharmD, MBA, BCPP
Medical Director, US Medical Affairs, Neuroscience, Otsuka America Pharmaceutical
More
Speaker Joseph Goldberg is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Karimah Lynum is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)